The Effect of Remimazolam on the Baseline TOF Ratio: A Prospective, Clinical Study

Overview

Journal Anesthesiol Res Pract

Publisher Wiley

Specialty Anesthesiology

Date 2024 Dec 6

PMID 39640500

Authors

Tomoko Yuruki

Masafumi Fujimoto

Naoyuki Hirata

Affiliations

Soon will be listed here.

Abstract

Remimazolam is a newly developed benzodiazepine. Early recovery from anesthesia because of its ultra-short acting effect and less hemodynamic side effects has been reported as the specific advantages of remimazolam. Therefore, the maintenance of anesthesia with propofol may be sometimes switched to remimazolam anesthesia maintenance during surgery because of the risk of delayed awakening and unstable hemodynamics. In the present study, to determine the influence of switching anesthesia from propofol to remimazolam on the baseline TOF ratio, the TOF ratio under remimazolam anesthesia maintenance without any neuromuscular blocking agents was compared to that calibrated after induction of general anesthesia with propofol. Twelve patients scheduled for elective surgery under general anesthesia in the supine position were investigated. After induction of general anesthesia with remifentanil and propofol, a supraglottic airway was inserted without neuromuscular blockade, and TOF stimulation every 15 s at the adductor pollicis muscle was started with acceleromyography. After stable baseline responses to TOF stimulation being obtained for at least 10 min under propofol anesthesia, the anesthetic agent was switched to remimazolam and TOF stimulation every 15 s was maintained for a further 60 min without any interruption. In each case, the averaged TOF ratio during the last 10 min of TOF monitoring was compared to that during the 10 min immediately before the beginning of remimazolam infusion using a paired -test. There were no significant differences in the TOF ratios before and after switching anesthesia to remimazolam (1.07 ± 0.03 vs. 1.07 ± 0.03, =0.325). Switching anesthesia from propofol to remimazolam does not affect the baseline TOF ratio.

References

Kopman A, Kumar S, Klewicka M, Neuman G . The staircase phenomenon: implications for monitoring of neuromuscular transmission. Anesthesiology. 2001; 95(2):403-7. DOI: 10.1097/00000542-200108000-00023. View

Suzuki T, Fukano N, Kitajima O, Saeki S, Ogawa S . Normalization of acceleromyographic train-of-four ratio by baseline value for detecting residual neuromuscular block. Br J Anaesth. 2005; 96(1):44-7. DOI: 10.1093/bja/aei273. View

Capron F, Alla F, Hottier C, Meistelman C, Fuchs-Buder T . Can acceleromyography detect low levels of residual paralysis? A probability approach to detect a mechanomyographic train-of-four ratio of 0.9. Anesthesiology. 2004; 100(5):1119-24. DOI: 10.1097/00000542-200405000-00013. View

Olkkola K, TAMMISTO T . Quantifying the interaction of rocuronium (Org 9426) with etomidate, fentanyl, midazolam, propofol, thiopental, and isoflurane using closed-loop feedback control of rocuronium infusion. Anesth Analg. 1994; 78(4):691-6. DOI: 10.1213/00000539-199404000-00013. View

Murphy G, Brull S . Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block. Anesth Analg. 2010; 111(1):120-8. DOI: 10.1213/ANE.0b013e3181da832d. View

Lee G, Iyengar S, Szenohradszky J, Caldwell J, Wright P, Brown R . Improving the design of muscle relaxant studies. Stabilization period and tetanic recruitment. Anesthesiology. 1997; 86(1):48-54. DOI: 10.1097/00000542-199701000-00008. View

Farkas S, Tarnawa I, Berzsenyi P . Effects of some centrally acting muscle relaxants on spinal root potentials: a comparative study. Neuropharmacology. 1989; 28(2):161-73. DOI: 10.1016/0028-3908(89)90053-1. View

Kamata K, Asagi S, Shimoda Y, Kanamori M, Abe N, Sugino S . Successful recording of direct cortical motor-evoked potential from a pediatric patient under remimazolam anesthesia: a case report. JA Clin Rep. 2022; 8(1):66. PMC: 9393118. DOI: 10.1186/s40981-022-00555-y. View

Bowman W . Prejunctional and postjunctional cholinoceptors at the neuromuscular junction. Anesth Analg. 1980; 59(12):935-43. View

10.

Doi M, Morita K, Takeda J, Sakamoto A, Yamakage M, Suzuki T . Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb/III trial. J Anesth. 2020; 34(4):543-553. DOI: 10.1007/s00540-020-02788-6. View

11.

Aoki Y, Ida M, Takatani T, Kawaguchi M . Motor-evoked potentials monitoring with remimazolam during thoracic descending aortic aneurysm surgery: a case report. J Anesth. 2023; 37(2):315-318. DOI: 10.1007/s00540-023-03168-6. View

12.

Arashiro A, Shinzato H, Kamizato K, Kakinohana M . Spinal fusion with motor evoked potential monitoring using remimazolam in Alström syndrome: A case report. Medicine (Baltimore). 2021; 100(47):e27990. PMC: 8615471. DOI: 10.1097/MD.0000000000027990. View

13.

Kirmeier E, Eriksson L, Lewald H, Jonsson Fagerlund M, Hoeft A, Hollmann M . Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study. Lancet Respir Med. 2018; 7(2):129-140. DOI: 10.1016/S2213-2600(18)30294-7. View

14.

Kilpatrick G, McIntyre M, Cox R, Stafford J, Pacofsky G, Lovell G . CNS 7056: a novel ultra-short-acting Benzodiazepine. Anesthesiology. 2007; 107(1):60-6. DOI: 10.1097/01.anes.0000267503.85085.c0. View

15.

Fujimoto M, Kubota F, Kaneda H . Effects of neuromuscular blockade on the surgical conditions of laparoscopic totally extraperitoneal inguinal hernia repair: a randomized clinical trial. Hernia. 2022; 26(4):1179-1186. DOI: 10.1007/s10029-022-02570-5. View

16.

Eriksson L, Sundman E, Olsson R, Nilsson L, Witt H, Ekberg O . Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans: simultaneous videomanometry and mechanomyography of awake human volunteers. Anesthesiology. 1997; 87(5):1035-43. DOI: 10.1097/00000542-199711000-00005. View

17.

Driessen J, Crul J, Vree T, van Egmond J, Booij L . Benzodiazepines and neuromuscular blocking drugs in patients. Acta Anaesthesiol Scand. 1986; 30(8):642-6. DOI: 10.1111/j.1399-6576.1986.tb02492.x. View

18.

Fuchs-Buder T, Brull S, Jonsson Fagerlund M, Renew J, Cammu G, Murphy G . Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents III: The 2023 Geneva revision. Acta Anaesthesiol Scand. 2023; 67(8):994-1017. DOI: 10.1111/aas.14279. View

19.

Yamada S, Akiyama Y, Tachibana S, Hayamizu K, Kimura Y, Hashimoto S . The intraoperative motor-evoked potential when propofol was changed to remimazolam during general anesthesia: a case series. J Anesth. 2022; 37(1):154-159. DOI: 10.1007/s00540-022-03112-0. View